Cara Welch Appointed Director of ODSP

Washington, D.C.—Cara Welch, Ph.D., has been appointed Director of the FDA Office of Dietary Supplement Programs, a move which was applauded by the Consumer Healthcare Products Association (CHPA).

“CHPA congratulates Dr. Welch on her permanent appointment as Director of ODSP,” said Duffy MacKay, CHPA’s SVP of Dietary Supplements. “This is a tremendous and well-deserved career achievement. Her experience, knowledge of the issues, and previous leadership at ODSP will surely be good for FDA and consumers. CHPA and ODSP are aligned in our mission: to ensure consumers have access to safe, high quality dietary supplements. We look forward to our continued partnership as we work together to modernize the regulatory framework for dietary supplements. With permanent leadership and a fully staffed ODSP, we anticipate FDA will be able to more proactively regulate the dietary supplements industry.”

Related: Senate Confirms Califf as FDA Commissioner
Industry Members Call FDA Inaction “Disheartening”
UNPA Submits Proof of NAC Pre-DSHEA Sale to FDA